HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 511 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $243,301,392 | +373.1% | 2,103,046 | +320.6% | 21.77% | +333.7% |
Q2 2023 | $51,425,000 | -52.9% | 500,000 | -50.0% | 5.02% | -44.7% |
Q1 2023 | $109,140,000 | -36.1% | 1,000,000 | -33.3% | 9.07% | -40.9% |
Q4 2022 | $170,700,000 | -54.8% | 1,500,000 | -75.4% | 15.36% | -44.4% |
Q3 2022 | $377,529,000 | -23.6% | 6,100,000 | -1.6% | 27.63% | +13.3% |
Q2 2022 | $494,432,000 | -16.3% | 6,199,000 | +10.4% | 24.38% | +34.1% |
Q1 2022 | $590,649,000 | -8.6% | 5,614,000 | -6.4% | 18.18% | -8.8% |
Q4 2021 | $646,560,000 | -4.3% | 6,000,000 | -2.7% | 19.94% | +3.5% |
Q3 2021 | $675,785,000 | -9.7% | 6,169,296 | -22.8% | 19.25% | +7.7% |
Q2 2021 | $748,318,000 | +1.7% | 7,991,440 | 0.0% | 17.88% | +5.8% |
Q1 2021 | $735,532,000 | +25.8% | 7,991,440 | 0.0% | 16.89% | +11.3% |
Q4 2020 | $584,574,000 | +12.5% | 7,991,440 | +19.4% | 15.17% | -6.3% |
Q3 2020 | $519,791,000 | +35.7% | 6,691,439 | -2.9% | 16.20% | +32.4% |
Q2 2020 | $383,026,000 | +58.3% | 6,891,439 | -15.7% | 12.24% | +32.5% |
Q1 2020 | $242,016,000 | -18.2% | 8,170,700 | 0.0% | 9.24% | +44.7% |
Q4 2019 | $295,779,000 | +32.9% | 8,170,700 | 0.0% | 6.38% | +43.3% |
Q3 2019 | $222,488,000 | +38.6% | 8,170,700 | +22.5% | 4.46% | +63.3% |
Q2 2019 | $160,497,000 | – | 6,670,700 | – | 2.73% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |